Halozyme Therapeutics Competitors and Similar CompaniesClear all
Karyopharm Therapeutics's competitors and similar companies include Blueprint Medicines.
 Karyopharm Therapeutics Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies. |  Blueprint Medicines Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders. | |
Founding Date | Founding Date 2008 | Founding Date 2011 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Newton, US HQ Givatayim, IL | Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH |
Employees | Employees 32516% decrease | Employees 6552% increase |
Valuation ($) | Valuation ($) 111.7 m | Valuation ($) 5.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) $145.2m (FY, 2024) | Revenue (est.) $508.8m (FY, 2024) |
Net income | Net income ($76.4m) (FY, 2024) | Net income ($67.1m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 248.7m | Total funding raised $ 1.7b |
For sources of this data, please see the company profile
View Company Profiles
Blueprint Medicines
HQ
Cambridge, US
Employees
655↑ 2% increase
Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders.
View company